Meriwether Wealth & Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
1,026
-11
-1% -$3.77K 0.18% 80
2026
Q1
$365K Sell
1,037
-31
-3% -$11.1K 0.2% 76
2025
Q4
$350K Sell
1,068
-73
-6% -$23.2K 0.2% 77
2025
Q3
$322K Sell
1,141
-140
-11% -$40.6K 0.19% 82
2025
Q2
$358K Sell
1,281
-364
-22% -$103K 0.22% 75
2025
Q1
$513K Buy
1,645
+44
+3% +$13K 0.33% 57
2024
Q4
$417K Buy
+1,601
New +$475K 0.3% 63

Other funds holding AMGN

Meriwether Wealth & Planning's AMGN Position: Q2 2026 in Review

Meriwether Wealth & Planning reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $3.77K and leaving 1,026 shares worth $372K. The position accounts for 0.18% of the portfolio, ranked #80.

Meriwether Wealth & Planning first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $513K in Q1 2025. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Meriwether Wealth & Planning held 1,026 shares of Amgen worth $372K as of Q2 2026.
  • Meriwether Wealth & Planning sold 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.18% of Meriwether Wealth & Planning's portfolio in Q2 2026, its #80 holding.
  • Meriwether Wealth & Planning first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Meriwether Wealth & Planning's Amgen position peaked at $513K in Q1 2025.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q2 2026, filed 8 Jul 2026.